Pfizer Future Growth

Future criteria checks 3/6

Pfizer is forecast to grow earnings and revenue by 31% and 2.8% per annum respectively. EPS is expected to grow by 30.8% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

31.0%

Earnings growth rate

30.8%

EPS growth rate

Pharmaceuticals earnings growth23.8%
Revenue growth rate2.8%
Future return on equity16.8%
Analyst coverage

Good

Last updated24 May 2024

Recent future growth updates

Recent updates

Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs

May 21

Pfizer's Bottom May Be Here - Its Rich Yield Is Tempting

May 12

Pfizer: Ignore The Dead Cat Bounce

May 06

Pfizer Inc.'s (NYSE:PFE) Price Is Out Of Tune With Revenues

May 03
Pfizer Inc.'s (NYSE:PFE) Price Is Out Of Tune With Revenues

Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?

Apr 29

Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth

Apr 19

Pfizer: The Market Is Wrong

Apr 11

Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns

Mar 18

Pfizer: A Strong Buy Trading Below A 10 P/E Ratio

Mar 08

Pfizer: A Value Trap, Not A Bargain

Feb 28

Pfizer: Turnaround Is Gaining Momentum

Feb 21

Is Pfizer (NYSE:PFE) A Risky Investment?

Feb 21
Is Pfizer (NYSE:PFE) A Risky Investment?

Pfizer Is A Great Investment Over The Next Decade; Buy

Feb 09

Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disagree With The Market

Jan 31

Earnings and Revenue Growth Forecasts

NYSE:PFE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202663,47311,42116,20519,13919
12/31/202562,73510,68314,74617,36122
12/31/202460,4866,70411,20117,04122
3/31/202454,889-2885,1068,578N/A
12/31/202358,4962,1344,7938,700N/A
10/1/202368,74110,4698,17812,042N/A
7/2/202378,14721,49410,66514,560N/A
4/2/202393,15429,03520,20623,938N/A
12/31/2022100,33031,36626,03129,267N/A
10/2/202299,87829,95323,36226,599N/A
7/3/2022101,27529,48128,44031,454N/A
4/3/202292,43325,41031,78334,583N/A
12/31/202181,28822,41329,86932,580N/A
10/3/202168,87719,48529,76932,291N/A
7/4/202155,11912,23621,14123,552N/A
4/4/202146,0849,03213,47715,808N/A
12/31/202041,6516,63012,17714,403N/A
9/27/202032,33421210,51212,547N/A
6/28/202034,7376,97712,77714,967N/A
3/29/202038,1379,42711,70214,023N/A
12/31/201940,90510,70710,54212,588N/A
9/29/201953,03916,21110,89713,557N/A
6/30/201953,65612,63811,74614,306N/A
3/31/201953,85911,46413,14615,542N/A
12/31/201840,8253,82413,69115,827N/A
9/30/201853,37323,80816,00118,178N/A
7/1/201853,24422,54515,59617,808N/A
4/1/201852,67321,74614,92417,201N/A
12/31/201752,54621,305N/A16,802N/A
10/1/201752,4719,791N/A15,463N/A
7/2/201752,3478,308N/A15,311N/A
4/2/201752,5987,281N/A15,677N/A
12/31/201652,8247,198N/A16,192N/A
10/2/201653,2436,270N/A15,049N/A
7/3/201652,2867,036N/A15,332N/A
4/3/201650,9927,615N/A15,816N/A
12/31/201548,8516,948N/A14,688N/A
9/27/201547,9228,366N/A15,188N/A
6/28/201548,1968,913N/A14,631N/A
3/29/201549,1169,200N/A14,628N/A
12/31/201449,6059,085N/A17,084N/A
9/28/201450,04510,461N/A17,209N/A
6/29/201450,32710,370N/A18,646N/A
3/30/201450,52710,994N/A18,316N/A
12/31/201351,58411,339N/A17,684N/A
9/29/201351,91710,185N/A16,908N/A
6/30/201352,22710,590N/A16,011N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PFE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: PFE is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PFE is expected to become profitable in the next 3 years.

Revenue vs Market: PFE's revenue (2.8% per year) is forecast to grow slower than the US market (8.4% per year).

High Growth Revenue: PFE's revenue (2.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PFE's Return on Equity is forecast to be low in 3 years time (16.8%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.